Yuval Tal

12 Bayit Street
Jerusalem, JM 91031, Israel

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 83 publications

Primary Prevention of IgE-mediated Cow's Milk Allergy Is Feasible: A Position Statement by the Israeli Association of Allergy and Clinical Immunology.

Primary Prevention of IgE-mediated Cow's Milk Allergy Is Feasible: A Position Statement by the Israeli Association of Allergy and Clinical Immunology.

Journal: The Israel Medical Association journal : IMAJ

Published: September 06, 2026

Clinical and population genetic insights into primary complement component 2 (C2) deficiency: A founder variant in Ashkenazi Jews.

Clinical and population genetic insights into primary complement component 2 (C2) deficiency: A founder variant in Ashkenazi Jews.

Journal: Clinical immunology (Orlando, Fla.)

Published: May 29, 2026

Clinical and population genetic insights into primary complement component 2 (C2) deficiency: A founder variant in Ashkenazi Jews.

Clinical and population genetic insights into primary complement component 2 (C2) deficiency: A founder variant in Ashkenazi Jews.

Journal: Clinical immunology (Orlando, Fla.)

Published: May 29, 2026

Key factors influencing medical residency choice among medical graduates.

Key factors influencing medical residency choice among medical graduates.

Journal: Israel journal of health policy research

Published: January 07, 2026

Severe eosinophilia and risk of major disease and mortality: A nationwide cohort study of children and adults.

Severe eosinophilia and risk of major disease and mortality: A nationwide cohort study of children and adults.

Journal: The journal of allergy and clinical immunology. Global

Published: October 29, 2025

NDUFS4, a mitochondrial complex I subunit, is essential for T-cell metabolic fitness and immune function.

NDUFS4, a mitochondrial complex I subunit, is essential for T-cell metabolic fitness and immune function.

Journal: Frontiers in immunology

Published: October 28, 2025

Case Report: A potential novel treatment for drug-induced acute interstitial nephritis: Benralizumab.

Case Report: A potential novel treatment for drug-induced acute interstitial nephritis: Benralizumab.

Journal: Frontiers in immunology

Published: October 08, 2025

Benralizumab for adults with rare and off-label eosinophilic disorders: a 52-week prospective, single-center study.

Benralizumab for adults with rare and off-label eosinophilic disorders: a 52-week prospective, single-center study.

Journal: Frontiers in immunology

Published: September 10, 2025

Challenging the routine: evaluating the need for postoperative management in blepharoplasty: a randomized controlled trial.

Challenging the routine: evaluating the need for postoperative management in blepharoplasty: a randomized controlled trial.

Journal: International ophthalmology

Published: July 15, 2025

Lab earthquakes reveal a wide range of rupture behaviors controlled by fault bends.

Lab earthquakes reveal a wide range of rupture behaviors controlled by fault bends.

Journal: Proceedings of the National Academy of Sciences of the United States of America

Published: April 25, 2025

β-Actin Deficiency in Baraitser-Winter Syndrome Type 1 Disrupts T-Cell Function and Immune Regulation: Implications for Targeted Therapy in Actinopathies.

β-Actin Deficiency in Baraitser-Winter Syndrome Type 1 Disrupts T-Cell Function and Immune Regulation: Implications for Targeted Therapy in Actinopathies.

Journal: Journal of clinical immunology

Published: March 26, 2025

First-in-class intranasal epinephrine spray for anaphylaxis: Dose finding clinical study.

First-in-class intranasal epinephrine spray for anaphylaxis: Dose finding clinical study.

Journal: The journal of allergy and clinical immunology. Global

Published: December 30, 2024

Showing 1-12 of 83

Last Updated: 09/26/2026